VIGGIANO, Davide
 Distribuzione geografica
Continente #
EU - Europa 2.838
NA - Nord America 1.568
AS - Asia 1.355
SA - Sud America 261
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 21
Totale 6.163
Nazione #
RU - Federazione Russa 1.927
US - Stati Uniti d'America 1.509
SG - Singapore 437
IT - Italia 345
CN - Cina 290
IE - Irlanda 251
HK - Hong Kong 232
BR - Brasile 202
VN - Vietnam 185
GB - Regno Unito 80
DE - Germania 74
IN - India 63
KR - Corea 56
AT - Austria 38
CA - Canada 30
AR - Argentina 25
FR - Francia 22
AE - Emirati Arabi Uniti 21
FI - Finlandia 19
UA - Ucraina 18
BD - Bangladesh 16
GR - Grecia 16
JP - Giappone 16
CZ - Repubblica Ceca 13
EC - Ecuador 13
NL - Olanda 11
MX - Messico 9
PK - Pakistan 9
SE - Svezia 8
CO - Colombia 7
IQ - Iraq 6
ZA - Sudafrica 6
GT - Guatemala 5
MA - Marocco 5
TR - Turchia 5
AL - Albania 4
CR - Costa Rica 4
ID - Indonesia 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
EG - Egitto 3
JM - Giamaica 3
PE - Perù 3
VE - Venezuela 3
BO - Bolivia 2
CL - Cile 2
EE - Estonia 2
EU - Europa 2
KE - Kenya 2
MW - Malawi 2
PL - Polonia 2
TN - Tunisia 2
VI - Stati Uniti Isole Vergini 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BM - Bermuda 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ES - Italia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
TT - Trinidad e Tobago 1
Totale 6.048
Città #
Moscow 686
Dublin 251
San Jose 244
Hong Kong 228
Singapore 205
Santa Clara 192
Ashburn 137
Council Bluffs 131
New York 69
Ho Chi Minh City 62
Seoul 56
Hefei 55
Naples 49
Hanoi 48
Chandler 43
Beijing 40
Bengaluru 40
Milan 38
Jacksonville 31
Los Angeles 30
Princeton 28
Roxbury 28
Chicago 25
Dallas 25
São Paulo 22
The Dalles 21
Nuremberg 20
Medford 19
Vienna 19
Aversa 17
Munich 14
Rome 14
Caserta 13
Bremen 12
Da Nang 12
Des Moines 12
Brno 11
Falkenstein 11
Atlanta 9
Cambridge 9
London 9
Miano 9
Tokyo 9
Amsterdam 8
Brasília 8
Ercolano 8
Memphis 8
Boardman 7
Phoenix 7
Tianjin 7
Turku 7
Wilmington 7
Chennai 6
Helsinki 6
Houston 6
Montreal 6
Salerno 6
Haiphong 5
Kochi 5
Lappeenranta 5
North Bergen 5
Rio de Janeiro 5
Ann Arbor 4
Bogotá 4
Brooklyn 4
Can Tho 4
Frankfurt am Main 4
Guangzhou 4
Guatemala City 4
Hải Dương 4
Itabira 4
Las Vegas 4
Nha Trang 4
Quito 4
Rho 4
Ribeirão Preto 4
Salvador 4
San Francisco 4
San Mango Piemonte 4
Toronto 4
Afragola 3
Asunción 3
Baghdad 3
Bari 3
Betim 3
Buenos Aires 3
Buffalo 3
Bắc Ninh 3
Cairo 3
Campinas 3
Caxias do Sul 3
Changsha 3
Chieti 3
Giugliano in Campania 3
Guayaquil 3
Huế 3
Islamabad 3
Istanbul 3
Joinville 3
Kingston 3
Totale 3.257
Nome #
Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cells. 174
Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation 171
Diuretic Resistance in Cardio-Nephrology: Role of Pharmacokinetics, Hypochloremia, and Kidney Remodeling 170
Delay in Renal Hemodynamic Response to a Meat Meal in Severe Obesity 168
How to assess kidney function in oncology patients 159
Urine concentrating defect as presenting sign of progressive renal failure in Bardet-Biedl syndrome patients 157
Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment 156
Corrigendum to “WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S637] 155
Brain dysfunction in tubular and tubulointerstitial kidney diseases 149
A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics 148
Another case of organ blindness in the history of combined eye-kidney disorders wilson’s disease 148
Animal models to study cognitive impairment of chronic kidney disease 144
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment 144
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? 144
Gut mucosa alterations after kidney transplantation: a cross sectional study 138
Kidney Transplant Modifies the Architecture and Microenvironment of Basal Cell Carcinomas 138
[Inflammation in kidney diseases] 136
A cross-sectional study on the relationship between hematological data and quantitative morphological indices from kidney biopsies in different glomerular diseases 135
How much time does it take to get cognitive impairment in kidney disease? 129
Plasma Calcium Concentration Modifies the Blood Sodium during hemodialysis: lessons from hard water syndrome 123
Molecular networks in Network Medicine: Development and applications 123
[Anti-MBG crescentic glomerulonephritis with negative immunofluorescence: case report and literature review] 120
A quest for protecting kidneys from cisplatin toxicity 117
Urinary proteome in inherited nephrolithiasis 117
Skin Architecture, Kidney Transplantation, and Their Relationship to Basal and Squamous Cell Carcinomas 113
Urate-lowering agents in asymptomatic hyperuricemia: Role of urine sediment analysis and musculoskeletal ultrasound 112
Mechanisms of cognitive dysfunction in CKD 112
Methods for calculating the number of nephrons from ultrasound scans and kidney biopsies for nephrologists’ use 112
Cellular and subcellular localization of uncoupling protein 2 in the human kidney 111
The renal lesions in Bardet-Biedl Syndrome: history before and after the discovery of BBS genes 109
Preliminary results of autologous adipose-derived stem cells in early knee osteoarthritis: identification of a subpopulation with greater response 104
Regulation of urinary calcium excretion by vasopressin 104
The number of nephrons in different glomerular diseases 104
A Reanalysis of Historical Figures With Depression and Dropsy 103
Therapeutic Monitoring of Post-COVID-19 Cognitive Impairment Through Novel Brain Function Assessment 100
Minor varus alignment provides better results than neutral alignment in medial UKA 100
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges 100
Epigenetics, Microbiome and Personalized Medicine: Focus on Kidney Disease 99
Mild cognitive impairment and kidney disease: Clinical aspects 98
Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia 91
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 89
The interplay between sodium/glucose cotransporter type 2 and mitochondrial ionic environment 88
Wall Tension and Tubular Resistance in Kidney Cystic Conditions 87
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients 86
Renal response to an oral protein load in patients with central diabetes insipidus before and after treatment with vasopressin 85
The need for a multi-disciplinary reflection about frailty and cognitive impairment in chronic kidney disease 83
The brain extracellular space in chronic kidney disease 79
Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease 75
miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network 73
The renal adverse effects of cancer immunotherapy 70
Present and future of CONNECT: a new and compelling project of modern medicine 56
Multiscale Imaging of Human Adipose Tissue: A Neglected Partner in Proteinuria Linked to Obesity 38
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor 30
Immunological Avalanches in Renal Immune Diseases 29
From stethoscope to ultrasound: an Italian survey of nephrology ultrasound practice 24
SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy 23
Virtual reality training for cognitive impairment in adults treated with haemodialysis (VIRTUAL): protocol for a multicentre, randomised, open-label feasibility trial 13
Totale 6.163
Categoria #
all - tutte 22.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022180 0 0 0 3 56 6 5 5 12 23 12 58
2022/2023350 32 8 7 21 21 9 4 15 212 4 9 8
2023/2024274 25 8 22 11 69 54 8 16 2 1 16 42
2024/2025901 21 2 9 15 106 132 149 83 127 119 76 62
2025/20263.538 171 194 191 170 310 1.786 193 117 165 150 66 25
2026/2027699 59 62 283 295 0 0 0 0 0 0 0 0
Totale 6.163